Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Hwp1 and related adhesins contribute to both mating and biofilm formation in Candida albicans.

Ene IV, Bennett RJ.

Eukaryot Cell. 2009 Dec;8(12):1909-13. doi: 10.1128/EC.00245-09. Epub 2009 Oct 16.

2.

The antagonistic effect of Saccharomyces boulardii on Candida albicans filamentation, adhesion and biofilm formation.

Krasowska A, Murzyn A, Dyjankiewicz A, Łukaszewicz M, Dziadkowiec D.

FEMS Yeast Res. 2009 Dec;9(8):1312-21. doi: 10.1111/j.1567-1364.2009.00559.x. Epub 2009 Aug 5.

3.

Arachidonic acid increases antifungal susceptibility of Candida albicans and Candida dubliniensis.

Ells R, Kock JL, Van Wyk PW, Botes PJ, Pohl CH.

J Antimicrob Chemother. 2009 Jan;63(1):124-8. doi: 10.1093/jac/dkn446. Epub 2008 Oct 29.

PMID:
18971215
4.

Effects of Saccharomyces boulardii on cytokine secretion from intraepithelial lymphocytes infected by Escherichia coli and Candida albicans.

Fidan I, Kalkanci A, Yesilyurt E, Yalcin B, Erdal B, Kustimur S, Imir T.

Mycoses. 2009 Jan;52(1):29-34. doi: 10.1111/j.1439-0507.2008.01545.x. Epub 2008 Jun 21.

PMID:
18627477
5.

C. albicans colonization of human mucosal surfaces.

Southern P, Horbul J, Maher D, Davis DA.

PLoS One. 2008 Apr 30;3(4):e2067. doi: 10.1371/journal.pone.0002067.

6.

Morphogenesis control in Candida albicans and Candida dubliniensis through signaling molecules produced by planktonic and biofilm cells.

Martins M, Henriques M, Azeredo J, Rocha SM, Coimbra MA, Oliveira R.

Eukaryot Cell. 2007 Dec;6(12):2429-36. Epub 2007 Nov 2.

8.

Epidemiology of invasive candidiasis: a persistent public health problem.

Pfaller MA, Diekema DJ.

Clin Microbiol Rev. 2007 Jan;20(1):133-63. Review.

9.

Whey-derived free fatty acids suppress the germination of Candida albicans in vitro.

Clément M, Tremblay J, Lange M, Thibodeau J, Belhumeur P.

FEMS Yeast Res. 2007 Mar;7(2):276-85. Epub 2006 Oct 10.

10.

Function of Candida albicans adhesin Hwp1 in biofilm formation.

Nobile CJ, Nett JE, Andes DR, Mitchell AP.

Eukaryot Cell. 2006 Oct;5(10):1604-10.

11.

Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation.

Buts JP, Dekeyser N, Stilmant C, Delem E, Smets F, Sokal E.

Pediatr Res. 2006 Jul;60(1):24-9. Epub 2006 May 11.

PMID:
16690953
12.

Mechanism of Candida albicans transformation in response to changes of pH.

Konno N, Ishii M, Nagai A, Watanabe T, Ogasawara A, Mikami T, Matsumoto T.

Biol Pharm Bull. 2006 May;29(5):923-6.

13.

Contribution of cell surface hydrophobicity protein 1 (Csh1p) to virulence of hydrophobic Candida albicans serotype A cells.

Singleton DR, Fidel PL Jr, Wozniak KL, Hazen KC.

FEMS Microbiol Lett. 2005 Mar 15;244(2):373-7.

14.
15.

cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol.

Cao YY, Cao YB, Xu Z, Ying K, Li Y, Xie Y, Zhu ZY, Chen WS, Jiang YY.

Antimicrob Agents Chemother. 2005 Feb;49(2):584-9.

16.

Inactivation of CaMIT1 inhibits Candida albicans phospholipomannan beta-mannosylation, reduces virulence, and alters cell wall protein beta-mannosylation.

Mille C, Janbon G, Delplace F, Ibata-Ombetta S, Gaillardin C, Strecker G, Jouault T, Trinel PA, Poulain D.

J Biol Chem. 2004 Nov 12;279(46):47952-60. Epub 2004 Sep 3.

17.

Candida infections of medical devices.

Kojic EM, Darouiche RO.

Clin Microbiol Rev. 2004 Apr;17(2):255-67. Review.

18.

Candida albicans secreted aspartyl proteinases in virulence and pathogenesis.

Naglik JR, Challacombe SJ, Hube B.

Microbiol Mol Biol Rev. 2003 Sep;67(3):400-28, table of contents. Review.

20.

Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule.

Ramage G, Saville SP, Wickes BL, López-Ribot JL.

Appl Environ Microbiol. 2002 Nov;68(11):5459-63.

Supplemental Content

Support Center